Research programme: antibiotics - NAICONS

Drug Profile

Research programme: antibiotics - NAICONS

Alternative Names: NAI 414; nai 414-A; NAI 414-A; nai 414-B; NAI 414-B; NAI 603; Nai 603; Orthoformimycin; PUM

Latest Information Update: 02 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NAICONS
  • Class Anti-infectives
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Peptide elongation factor G inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Gram-negative infections; Gram-positive infections; Solid tumours

Most Recent Events

  • 02 Dec 2015 Preclinical trials in Gram-negative infections in Italy (unspecified route)
  • 02 Dec 2015 Preclinical trials in Gram-positive infections in Italy (IV)
  • 02 Dec 2015 Preclinical trials in Gram-positive infections in Italy (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top